By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
'Scary Smart' Dives Into The Future Of AI
Mo Gawdat, author of 'Scary Smart: The Future of Artificial Intelligence and How You Can Save Our World' joins Cheddar News to discuss his book that dives into the future of AI.
Stock Standouts: Tuesday, October 26
Cheddar News' Closing Bell featured some of the day's biggest market movers. Today's stock standouts were four companies reporting their latest quarterly results: Facebook, UPS, Google parent company Alphabet, and Robinhood.
Dow, S&P Hit Record Close Again, Microsoft Reports Earnings
Chuck Lieberman, Partner and CIO at Advisors Capital Management, joins Cheddar News' Closing Bell, where he provides his insights on what we've seen during earnings season thus far and breaks down Microsoft's latest figures as the tech giant reports its quarterly earnings.
DraftKings Drops $22 Billion Bid for Entain
DraftKings is walking away from a deal to buy Entain, a major company in the international gambling industry, for $22.4 billion. The deal reportedly fell through after the companies could not come to agreements about BetMGM, the exclusive sports betting division of MGM, and a joint venture between MGM resorts and Entain. Sportico sports business reporter Eben Novy-Williams joined Cheddar Nws' Closing Bell to discuss.
Facebook Setting Its Sights on Metaverse as Part of Rebranding
Facebook has dominated the headlines over the past week. The social media giant reported earnings on Monday, has been in the crosshairs of lawmakers and is now expected to rebrand itself as it gears up for what it calls the metaverse. Daniel Newman, Founder & Principal Analyst at Futurum Research, joins Cheddar News' Closing Bell where he discusses what we should expect to see ultimately unfold.
Amalgamated Bank Commits to Reducing Emissions
Amalgamated Bank is the first U.S. bank to publish science-based targets to reach net-zero greenhouse gas emissions by 2045. The bank says it will reach this goal through how it engages with customers and how it finances projects. Amalgamated Bank Chief Sustainability Officer Ivan Frishberg joined Cheddar Climate to provide more details about the bank's ambitious climate goals.
Load More